Medicenna Therapeutics Corp. (MDNA) Tops Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts MDNA Hot Sheet
Join SI Premium – FREE
Medicenna Therapeutics Corp. (NASDAQ: MDNA) reported Q1 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06).
For earnings history and earnings-related data on Medicenna Therapeutics Corp. (MDNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Celcuity (CELC) Reiterates at Market Outperform by Citizens Ahead of Upcoming Launch
- OceanaGold to acquire Ausgold in a deal valued at A$776M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
